medical progress Trans Fatty Acids and Cardiovascular Disease

  title={medical progress Trans Fatty Acids and Cardiovascular Disease},
  author={Dariush Mozaffarian and Martijn Bernard Katan and Alberto A Ascherio and Meir Jonathan Stampfer and Walter C. Willett},
From the Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, and the Departments of Nutrition and Epidemiology, Harvard School of Public Health — all in Boston (D.M., A.A., M.J.S., W.C.W.); and the Division of Human Nutrition, Wageningen University, and Wageningen Center for Food Sciences — both in Wageningen, the Netherlands (M.B.K.). Address reprint requests to Dr. Mozaffarian at the Harvard School of Public Health, 665 Huntington Ave., Bldg… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 17 extracted citations


Publications referenced by this paper.
Showing 1-10 of 72 references

Labelling of trans fatty acid content in food , regulations , and what limits pros et cons — the Danish view

  • HG Jensen
  • First International Symposium on Trans Fatty…
  • 2005

Lightly hydrogenated soy oil versus other vegetable 5 . 6 . 7 . 8 . oils as a lipidlowering dietary constitu

  • DC Laine, CM Snodgrass, EA Dawson, MA Ener, K Kuba, ID Frantz
  • Am J Clin Nutr
  • 2005

Similar Papers

Loading similar papers…